Cargando…
Expression of tumour-specific antigens underlies cancer immunoediting
Cancer immunoediting is a process by which immune cells, particularly lymphocytes of the adaptive immune system, protect the host from the development of cancer and alter tumour progression by driving the outgrowth of tumour cells with decreased sensitivity to immune attack(1,2). Carcinogen-induced...
Autores principales: | DuPage, Michel, Mazumdar, Claire, Schmidt, Leah M., Cheung, Ann F., Jacks, Tyler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288744/ https://www.ncbi.nlm.nih.gov/pubmed/22318517 http://dx.doi.org/10.1038/nature10803 |
Ejemplares similares
-
Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation
por: Schmidt, Leah, et al.
Publicado: (2019) -
Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013) -
Gene essentiality for tumour growth influences neoantigen‐directed immunoediting
por: Bang, Hyoeun, et al.
Publicado: (2022) -
Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012) -
Exosomes in cancer immunoediting and immunotherapy
por: Zhao, Yarong, et al.
Publicado: (2022)